Impact of Modified HFPEF Score on Chronic Limb-Threatening Ischemia in Patients With Lower Extremity Artery Disease Who Underwent Endovascular Therapy

Overview

Journal Circ Rep

Date 2022 Aug 29

PMID 36032384

Authors

Taku Shikama

Yoichiro Otaki

Tetsu Watanabe

Hiroki Takahashi

Tasuku Kurokawa

Harutoshi Tamura

Shigehiko Kato

Satoshi Nishiyama

Takanori Arimoto

Masafumi Watanabe

Affiliations

Soon will be listed here.

Abstract

Lower extremity artery disease (LEAD) is an arterial occlusive disease characterized by an insufficient blood supply to the lower limb arteries. The HFPEF score, comprising Heavy, Hypertensive, atrial Fibrillation, Pulmonary hypertension, Elder, and Filling pressure, has been developed to identify patients at high risk of heart failure (HF) with preserved ejection fraction. This study assessed the impact of modified HFPEF scores on chronic limb-threatening ischemia (CLTI) in patients with LEAD. This study was a prospective observational study. Because the definition of obesity differs by race, we calculated the modified HFPEF score using a body mass index >25 kg/m to define obesity in 293 patients with LEAD who underwent first endovascular therapy. The primary endpoints were newly developed and recurrent CLTI. The secondary endpoint was a composite of events, including mortality and rehospitalization due to worsening HF and/or CLTI. The modified HFPEF score increased significantly with advancing Fontaine classes. Multivariate Cox proportional hazard analysis revealed that the modified HFPEF score was an independent predictor of newly developed and recurrent CLTI and composite events. The net reclassification index and integrated discrimination improvement were significantly improved by adding the modified HFPEF score to the basic predictors. The modified HFPEF score was associated with LEAD severity and future CLTI development, suggesting that it could be a feasible marker for patients with LEAD.

References

Chow B, Rabkin S . The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis. Heart Fail Rev. 2015; 20(3):291-303. DOI: 10.1007/s10741-015-9471-1. View

Hicks C, Yang C, Ndumele C, Folsom A, Heiss G, Black 3rd J . Associations of Obesity With Incident Hospitalization Related to Peripheral Artery Disease and Critical Limb Ischemia in the ARIC Study. J Am Heart Assoc. 2018; 7(16):e008644. PMC: 6201405. DOI: 10.1161/JAHA.118.008644. View

Bekwelem W, Norby F, Agarwal S, Matsushita K, Coresh J, Alonso A . Association of Peripheral Artery Disease With Incident Atrial Fibrillation: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Assoc. 2018; 7(8). PMC: 6015443. DOI: 10.1161/JAHA.117.007452. View

Dua A, Lee C . Epidemiology of Peripheral Arterial Disease and Critical Limb Ischemia. Tech Vasc Interv Radiol. 2016; 19(2):91-5. DOI: 10.1053/j.tvir.2016.04.001. View

Norgren L, Hiatt W, Dormandy J, Nehler M, Harris K, Fowkes F . Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007; 45 Suppl S:S5-67. DOI: 10.1016/j.jvs.2006.12.037. View

ORourke M . Diastolic heart failure, diastolic left ventricular dysfunction and exercise intolerance. J Am Coll Cardiol. 2001; 38(3):803-5. DOI: 10.1016/s0735-1097(01)01452-8. View

Teraa M, Conte M, Moll F, Verhaar M . Critical Limb Ischemia: Current Trends and Future Directions. J Am Heart Assoc. 2016; 5(2). PMC: 4802465. DOI: 10.1161/JAHA.115.002938. View

Bhatia R, Tu J, Lee D, Austin P, Fang J, Haouzi A . Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006; 355(3):260-9. DOI: 10.1056/NEJMoa051530. View

Sandesara P, Hammadah M, Samman-Tahhan A, Kelli H, ONeal W . Peripheral artery disease and risk of adverse outcomes in heart failure with preserved ejection fraction. Clin Cardiol. 2017; 40(9):692-696. PMC: 5610588. DOI: 10.1002/clc.22716. View

10.

Carbone S, Lavie C, Elagizi A, Arena R, Ventura H . The Impact of Obesity in Heart Failure. Heart Fail Clin. 2019; 16(1):71-80. DOI: 10.1016/j.hfc.2019.08.008. View

11.

Aboyans V, Ricco J, Bartelink M, Bjorck M, Brodmann M, Cohnert T . Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2017; 55(3):305-368. DOI: 10.1016/j.ejvs.2017.07.018. View

12.

Kim M, Yu H, Kim T, Uhm J, Joung B, Lee M . One-Year Change in the HFPEF Score After Catheter Ablation of Atrial Fibrillation in Patients With a Normal Left Ventricular Systolic Function. Front Cardiovasc Med. 2021; 8:699364. PMC: 8369029. DOI: 10.3389/fcvm.2021.699364. View

13.

Sun Y, Wang N, Li X, Zhang Y, Yang J, Tse G . Predictive value of H FPEF score in patients with heart failure with preserved ejection fraction. ESC Heart Fail. 2021; 8(2):1244-1252. PMC: 8006728. DOI: 10.1002/ehf2.13187. View

14.

Selvaraj S, Myhre P, Vaduganathan M, Claggett B, Matsushita K, Kitzman D . Application of Diagnostic Algorithms for Heart Failure With Preserved Ejection Fraction to the Community. JACC Heart Fail. 2020; 8(8):640-653. PMC: 8030634. DOI: 10.1016/j.jchf.2020.03.013. View

15.

Yanaka K, Akahori H, Imanaka T, Miki K, Yoshihara N, Tanaka T . The impact of peripheral artery disease on left ventricular diastolic function. J Cardiol. 2019; 73(6):453-458. DOI: 10.1016/j.jjcc.2019.01.011. View

16.

Otaki Y, Watanabe T, Takahashi H, Yamaura G, Nishiyama S, Arimoto T . Serum carboxy-terminal telopeptide of type I collagen (I-CTP) is predictive of clinical outcome in peripheral artery disease patients following endovascular therapy. Heart Vessels. 2016; 32(2):149-156. DOI: 10.1007/s00380-016-0858-2. View

17.

Watanabe K, Takahashi H, Watanabe T, Otaki Y, Kato S, Tamura H . Endovascular Revascularization Improves the Central Hemodynamics and Augmentation Index in Patients with Peripheral Artery Disease. Intern Med. 2019; 59(1):37-44. PMC: 6995708. DOI: 10.2169/internalmedicine.3413-19. View

18.

Murray G, Butcher I, Heald C, Lee R, Chambless L, Folsom A . Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008; 300(2):197-208. PMC: 2932628. DOI: 10.1001/jama.300.2.197. View

19.

Conte M, Bradbury A, Kolh P, White J, Dick F, Fitridge R . Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019; 69(6S):3S-125S.e40. PMC: 8365864. DOI: 10.1016/j.jvs.2019.02.016. View

20.

Gerhard-Herman M, Gornik H, Barrett C, Barshes N, Corriere M, Drachman D . 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016; 135(12):e726-e779. PMC: 5477786. DOI: 10.1161/CIR.0000000000000471. View